A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells.

Genetic diseases and knockout mice stress the importance of matrix metalloproteinases (MMPs) in skeletal turnover. Our study aims at clarifying which MMPs are expressed by osteoclasts. Previous analyses of this basic question led to conflicting reports in the literature. In the present study, we used a variety of approaches: PCR, Northern blots, Slot blots, in situ hybridization, and immunohistochemistry. We analyzed osteoclasts in culture as well as osteoclasts in native bone at different locations and compared mouse and rabbit osteoclasts. Osteoclasts express MMP-9 and -14 in all conditions, although to a variable extent, and they are able to synthesize MMP-3, -10, and -12, at least under some circumstances. The induction of a given MMP in osteoclasts is influenced by its environment (e.g., osteoclast culture vs. native bone, and various sites within the same bone) and depends on the species (e.g., mouse vs. rabbit). Osteoclasts show high amounts of MMP-2 and -13 protein presumably made to a large extent by other cells, thereby documenting how proteinases of nonosteoclastic origin may contribute to osteoclast activities and giving insight in why the resorptive activity of purified osteoclasts appears insensitive to MMP inhibitors. Our study shows that the confusion about osteoclastic MMPs in the literature reflects the remarkable ability of osteoclasts to adapt to their environment, as required by the structural or functional diversity of bone tissue. Our observations provide basic information needed for understanding the emerging role of MMPs in controlling cell signaling and bone resorption.

[1]  T. Chambers,et al.  Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts. , 1995, Journal of cell science.

[2]  Thiennu H. Vu,et al.  Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones , 2000, The Journal of cell biology.

[3]  J. Compston,et al.  Distribution of matrix metalloproteinases and their inhibitor, TIMP‐1, in developing human osteophytic bone , 1997, Journal of anatomy.

[4]  C. Munaut,et al.  High Expression of 92‐kDa Type IV Collagenase (Gelatinase) in the Osteoclast Lineage during Mouse Development , 1994, Annals of the New York Academy of Sciences.

[5]  D. Sakai,et al.  Osteoclast molecular phenotyping by random cDNA sequencing. , 1995, Bone.

[6]  E. Wagner,et al.  c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. , 1994, Science.

[7]  F. Reinholt,et al.  Chondroclasts and Osteoclasts in Bones of Young Rats: Comparison of Ultrastructural and Functional Features , 1998, Calcified Tissue International.

[8]  Y. Okada,et al.  A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[9]  J. Compston,et al.  Tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) distribution in normal and pathological human bone. , 1999, Bone.

[10]  W R Taylor,et al.  Osteoclastogenesis is repressed by mechanical strain in an in vitro model , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[11]  J. Compston,et al.  Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: potential roles in skeletal development. , 1998, Bone.

[12]  L. Liotta,et al.  Urinary type IV collagenase: elevated levels are associated with bladder transitional cell carcinoma. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  R. Hembry,et al.  Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate. , 1989, The Journal of bone and joint surgery. American volume.

[14]  C. Miyaura,et al.  Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. , 1998, Endocrinology.

[15]  G. Stein,et al.  Responsiveness of gene expression markers of osteoblastic and osteoclastic activity to calcitonin in the appendicular and axial skeleton of the rat in vivo , 1994, Calcified Tissue International.

[16]  B. Rifkin Biology and Physiology of the Osteoclast , 1992 .

[17]  J. Compston,et al.  Production of collagenase by human osteoblasts and osteoclasts in vivo. , 1996, Bone.

[18]  J. Delaissé,et al.  The Migration of Purified Osteoclasts Through Collagen Is Inhibited by Matrix Metalloproteinase Inhibitors , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  D. Rice,et al.  Detection of gelatinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development. , 1997, Bone.

[20]  H. Hatano,et al.  Spatiotemporal change of rat collagenase (MMP-13) mRNA expression in the development of the rat femoral neck , 2000, Journal of Bone and Mineral Metabolism.

[21]  J. Delaisse,et al.  Bone-resorbing agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue. , 1988, Endocrinology.

[22]  Nils Brünner,et al.  Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  R. Gay,et al.  Membrane-type-1 matrix metalloproteinase is abundantly expressed in fibroblasts and osteoclasts at the bone-implant interface of aseptically loosened joint arthroplasties in situ. , 1999, The Journal of rheumatology.

[24]  V. Quesada,et al.  Identification and Enzymatic Characterization of Two Diverging Murine Counterparts of Human Interstitial Collagenase (MMP-1) Expressed at Sites of Embryo Implantation* , 2001, The Journal of Biological Chemistry.

[25]  C. López-Otín,et al.  Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[26]  P. Billings,et al.  Authentic Matrix Vesicles Contain Active Metalloproteases (MMP) , 2001, The Journal of Biological Chemistry.

[27]  U. Felbor,et al.  Generation and degradation of human endostatin proteins by various proteinases , 2000, FEBS letters.

[28]  D. Beier,et al.  The Matrix Metalloproteinase-14 (MMP-14) Gene Is Structurally Distinct from Other MMP Genes and Is Co-expressed with the TIMP-2 Gene during Mouse Embryogenesis* , 1997, The Journal of Biological Chemistry.

[29]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[30]  W. Stetler-Stevenson,et al.  Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  S. Théoleyre,et al.  Osteoprotegerin differentially regulates protease expression in osteoclast cultures. , 2002, Biochemical and biophysical research communications.

[32]  Y. Okada,et al.  Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[33]  J. Heino,et al.  Collagenase‐3 (MMP‐13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[34]  M. C. Ovejero,et al.  Matrix metalloproteinase-12 (MMP-12) in osteoclasts: new lesson on the involvement of MMPs in bone resorption. , 2004, Bone.

[35]  L. Blavier,et al.  Tissue inhibitor of metalloproteinases-2 is expressed in the interstitial matrix in adult mouse organs and during embryonic development. , 1997, Molecular biology of the cell.

[36]  G. Vaes,et al.  Purification of procollagenase and collagenase by affinity chromatography on sepharose—collagen , 1977, FEBS letters.

[37]  Y. Liu,et al.  Yeast Nuclear Extract Contains Two Major Forms of RNA Polymerase II Mediator Complexes* , 2001, The Journal of Biological Chemistry.

[38]  J. Delaissé,et al.  Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. , 1995, Journal of cell science.

[39]  M. C. Ovejero,et al.  Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. , 1997, Journal of cell science.

[40]  G. Vaes Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts. , 1988, Clinical orthopaedics and related research.

[41]  I. Stamenkovic,et al.  Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. , 2000, Genes & development.

[42]  R. Hembry,et al.  The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. , 1994, Journal of cell science.

[43]  L. Holliday,et al.  Initiation of Osteoclast Bone Resorption by Interstitial Collagenase* , 1997, The Journal of Biological Chemistry.

[44]  C. P. Leblond,et al.  Active gelatinase B is identified by histozymography in the cartilage resorption sites of developing long bones , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.

[45]  R. Baron,et al.  (Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment. , 1993, Journal of cell science.

[46]  A. Strongin,et al.  Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.

[47]  Jack P. Witty,et al.  Parathyroid hormone‐induced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[48]  Gabriele Bergers,et al.  MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.

[49]  J. Delaissé,et al.  Cysteine Proteinases and Matrix Metalloproteinases Play Distinct Roles in the Subosteoclastic Resorption Zone , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[50]  G. Segre,et al.  Heterogeneity among cells that express osteoclast-associated genes in developing bone. , 1998, Endocrinology.

[51]  D. G. Walker,et al.  A collagenolytic factor in rat bone promoted by parathyroid extract. , 1964, Biochemical and biophysical research communications.

[52]  H. Takahashi,et al.  Expression of metalloproteinase-13 (Collagenase-3) is induced during fracture healing in mice. , 1999, Bone.

[53]  H. Kawashima,et al.  Identification of matrix metalloproteinase 9 in rabbit osteoclasts. , 1994, The Journal of biological chemistry.

[54]  J. Delaissé,et al.  Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities , 2003, Microscopy research and technique.

[55]  S. Krane,et al.  Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice. , 1999, The Journal of clinical investigation.

[56]  P. Saftig,et al.  The Bone Lining Cell: Its Role in Cleaning Howship's Lacunae and Initiating Bone Formation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[57]  M. Karsdal,et al.  Transforming Growth Factor-β-induced Osteoblast Elongation Regulates Osteoclastic Bone Resorption through a p38 Mitogen-activated Protein Kinase- and Matrix Metalloproteinase-dependent Pathway* , 2001, The Journal of Biological Chemistry.

[58]  M. Mastrogiacomo,et al.  Retinoic acid induces cell proliferation and modulates gelatinases activity in human osteoclast-like cell lines. , 1996, Biochemical and biophysical research communications.

[59]  W. Stetler-Stevenson,et al.  Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3 , 1996, Cell.

[60]  E. Wagner,et al.  Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[61]  H. Sato,et al.  Complex Regulation of Membrane-type Matrix Metalloproteinase Expression and Matrix Metalloproteinase-2 Activation by Concanavalin a in Mda-mb-231 Human Breast Cancer Cells1 Activation of Which Has Been Associated with Metastatic Progression in Human Breast Cancer (hbc). Concanavalin a (con A) Has Be , 2022 .

[62]  M. Karsdal,et al.  The Type I Collagen Fragments ICTP and CTX Reveal Distinct Enzymatic Pathways of Bone Collagen Degradation , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[63]  A. Tumber,et al.  Stromelysin (MMP‐3) Synthesis Is Up‐Regulated in Estrogen‐Deficient Mouse Osteoblasts In Vivo and In Vitro , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[64]  M. Karsdal,et al.  Matrix Metalloproteinase-dependent Activation of Latent Transforming Growth Factor-β Controls the Conversion of Osteoblasts into Osteocytes by Blocking Osteoblast Apoptosis* , 2002, The Journal of Biological Chemistry.

[65]  P. Angel,et al.  Localisation of matrix metalloproteinases and TIMP-2 in resorbing mouse bone , 2000, Cell and Tissue Research.

[66]  Z. Werb,et al.  How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.

[67]  C. López-Otín,et al.  The Role of the C-terminal Domain of Human Collagenase-3 (MMP-13) in the Activation of Procollagenase-3, Substrate Specificity, and Tissue Inhibitor of Metalloproteinase Interaction* , 1997, The Journal of Biological Chemistry.

[68]  J. Aubin,et al.  Individual osteoblasts in the developing calvaria express different gene repertoires. , 2001, Bone.

[69]  J. Case,et al.  Transin/stromelysin expression in the synovium of rats with experimental erosive arthritis. In situ localization and kinetics of expression of the transformation-associated metalloproteinase in euthymic and athymic Lewis rats. , 1989, The Journal of clinical investigation.

[70]  H. Shimokawa,et al.  Detection of collagenase mRNA in odontoclasts of bovine root-resorbing tissue by In situ hybridization , 1993, Calcified Tissue International.

[71]  S. Nesbitt,et al.  Integrins on rat osteoclasts: Characterization of two monoclonal antibodies (F4 and F11) to rat β3 , 1992 .

[72]  C. López-Otín,et al.  A regulatory cascade involving retinoic acid, Cbfa1, and matrix metalloproteinases is coupled to the development of a process of perichondrial invasion and osteogenic differentiation during bone formation , 2001, The Journal of cell biology.

[73]  Lynda F. Bonewald,et al.  Proteolysis of Latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by Osteoclasts , 2002, The Journal of Biological Chemistry.

[74]  C. P. Leblond,et al.  Enzymes active in the areas undergoing cartilage resorption during the development of the secondary ossification center in the tibiae of rats aged 0–21 days. II. Two proteinases, gelatinase B and collagenase‐3, are implicated in the lysis of collagen fibrils , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.

[75]  D. Tacha,et al.  Casein Reduces Nonspecific Background Staining in Immunolabeling Techniques , 1992 .

[76]  V. Everts,et al.  Matrix Metalloproteinase Inhibitors Block Osteoclastic Resorption of Calvarial Bone but not the Resorption of Long Bone , 1999, Annals of the New York Academy of Sciences.